Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on the development of a portfolio of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options. Leveraging extensive domain expertise, we have identified and acquired or in-licensed a portfolio of development-stage proprietary compounds with what we believe are innovative mechanisms of action. Our executive management team includes globally recognized specialists in central nervous system diseases addressing significant unmet medical needs.
Company Details
- Employees
- 9
- Address
- Waltham, Ma
- Phone
- (908)683-8300
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- minervaneurosciences.com
- Keywords
- Schizophrenia, Major Depressive Disorder, Insomnia, Negative Symptoms, Parkinson's Disease, Central Nervous System Disorders.
- HQ
- Waltham, MA
Minerva Neurosciences Questions
Minerva Neurosciences's helpline number is (908)683-8300
Minerva Neurosciences's website is minervaneurosciences.com
Minerva Neurosciences's LinkedIn profile is https://www.linkedin.com/company/minerva-neurosciences
Minerva Neurosciences has
9 employees.
View email and phone details for 9
employees at Minerva Neurosciences.
Minerva Neurosciences's industry is
Pharmaceutical Manufacturing
Minerva Neurosciences's top competitors are
Applied Therapeutics, Inc.,
Ergot Biosciences,
Tract Bio,
Sapien Llc,
Freya Biosciences,
Ferring Pharmaceuticals,
Minerva Biotechnologies,
Vigil Neuroscience,
Neuroscouting,
Friends Of The South Shore Country Club.
Minerva Neurosciences's categories are Pharmaceutical Manufacturing
